J&J forecasts disappointing 2019 sales, defends talc safety

Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts’ estimates and said it expected further pressure on U.S. prescription drug prices, weighing on the broader pharmaceutical sector.

…read more

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Source:: Reuters – Business News